publication venue for Conformation-Based Restrictions and Scaffold Replacements in the Design of Hepatitis C Virus Polymerase Inhibitors: Discovery of Deleobuvir (BI 207127). 57:1845-1854. 2014 A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Discovery of Potent and Specific Tripeptide Inhibitors. 47:6584-6594. 2004 Discovery of Small-Molecule Inhibitors of the ATPase Activity of Human Papillomavirus E1 Helicase. 47:18-21. 2004 Peptide-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Structure−Activity Relationship at theC-Terminal Position. 47:2511-2522. 2004 Nonpeptidic, Monocharged, Cell Permeable Ligands for the p56lck SH2 Domain. 44:2421-2431. 2001 Ligands for the Tyrosine Kinase p56lckSH2 Domain: Discovery of Potent Dipeptide Derivatives with Monocharged, Nonhydrolyzable Phosphate Replacements. 42:1757-1766. 1999 Phosphotyrosine-Containing Dipeptides as High-Affinity Ligands for the p56lckSH2 Domain. 42:722-729. 1999